Welcome to our dedicated page for Modern Mobility Aids news (Ticker: MDRM), a resource for investors and traders seeking the latest updates and insights on Modern Mobility Aids stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Modern Mobility Aids's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Modern Mobility Aids's position in the market.
Summary not available.
Summary not available.
Summary not available.
Modern Mobility Aids, Inc. (OTC: MDRM) provided its annual shareholder letter, highlighting significant developments over the past year. The company successfully launched virtual-care clinics in Ontario and is expanding its services, including annual truck driver physicals. A key achievement is the near-completion of the acquisition of 2542153 Ontario Ltd, which generates over a million dollars in revenue. Plans to expand into West Africa and the development of a custom telehealth platform with Digital-Care are also noted. The company aims for revenue growth and full OTC market reporting in Q1 2023.
Galileo Life Sciences Inc. (OTC: MDRM) has announced the commencement of revenue generation and plans for expansion. Operating in Ontario, the company aims to enhance healthcare accessibility through its telehealth platform, providing virtual consultations at pharmacies. Currently, three clinics serve the Toronto area, with a target of 25 by year-end 2022. An agreement with 2542153 Ontario Inc. facilitates access to licensed virtual care physicians. CEO Tito DiMarco emphasizes the company's commitment to growth and profitability, leveraging advanced technology for quality patient care.
Galileo Life Sciences Inc (OTC: MDRM), also known as Modern Mobility Aids, is set to open its first telehealth clinic, "Virtual-Care-Plus" (VCPlus), on October 17, 2021, in Brampton, Ontario. By the end of October, two more VCPlus clinics will open in Markham and North York. The company has enlisted licensed primary care physicians to provide virtual consultations, utilizing secure technology from AMD Global Telemedicine. The global telehealth market is projected to grow from $90 billion in 2021 to $636 billion by 2028, signifying a robust opportunity for Galileo's innovative services.
Galileo Life Sciences has positioned itself at the forefront of the telehealth industry by offering robust solutions that integrate advanced technology for real-time patient monitoring. The company aims to expand globally with virtual clinics, particularly in regions like India, Pakistan, and Colombia. The global telemedicine market is projected to reach USD 298.9 billion by 2028, with a CAGR of 22.4%. This growth is driven by rising chronic illnesses and the need for cost-effective healthcare solutions.
FAQ
What is the current stock price of Modern Mobility Aids (MDRM)?
What is the market cap of Modern Mobility Aids (MDRM)?
